Qing Qing Wu

Qing Qing Wu

Auto-generated profile, based on publicly available information

Qing Qing Wu

Department of Cardiology Zhongnan Hospital of Wuhan University Wuhan China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
CLChen Liu
Chen Liu
QYQi Yao
Qi Yao
THTongtong Hu
Tongtong Hu
ZCZhulan Cai
Zhulan Cai
QXQingwen Xie
Qingwen Xie
QWQing Qing Wu
Qing Qing Wu
Cathepsin B (CTSB), a member of lysosomal cathepsin, is involved in cell autophagy and apoptosis. We previously reported that CTSB increased cardiomyocyte apoptosis in mice heart during pressure overload, while the role of CTSB on diabetic cardiomyopathy has not been fully elucidated. The aim of this study is to explore the role and the underlying mechanism of CTSB on diabetic cardiomyopathy. Mice were subjected to streptozotocin injection to induce a diabetes model. Neonatal rat cardiomyocytes were isolated and cultured with high glucose (33.3 mM) to establish an in vitro model. CTSB protein level was increased in diabetic cardiomyopathy (DCM) mice heart as well as in cardiomyocytes stimulated with high glucose. CTSB knockout mice showed ameliorated cardiac function, cardiac fibrosis, cardiac inflammation, and pyroptosis level. Oppositely, DCM mice with CTSB transgene showed exacerbated cardiac dysfunction, fibrosis, inflammation, and pyroptosis. We found that CTSB could bind to NLR family pyrin domain containing 3 (NLRP3), thus increasing the activation of the NLRP3/caspase-1 inflammasome pathway. When we used a NLRP3 knockout mice, the deteriorating effect of CTSB overexpression via adeno-associated virus (AAV)9 delivery was abolished. Taken together, CTSB aggravates diabetic cardiomyopathy via promoting NLRP3-mediated pyroptosis.

12 November 2020 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
ZCZhuLan Cai
ZhuLan Cai
QXQingwen Xie
Qingwen Xie
THTongtong Hu
Tongtong Hu
QYQi Yao
Qi Yao
JZJinhua Zhao
Jinhua Zhao
QTQizhu Tang
Qizhu Tang
Myocardial infarction (MI), the main cause of cardiovascular-related deaths worldwide, has long been a hot topic because of its threat to public health. S100A8/A9 has recently attracted an increasing amount of interest as a crucial alarmin that regulates the pathogenesis of cardiovascular disease after its release from myeloid cells. However, the role of S100A8/A9 in the etiology of MI is not well understood. Here, we elaborate on the critical roles and potential mechanisms of S100A8/A9 driving the pathogenesis of MI. First, cellular source of S100A8/A9 in infarcted heart is discussed. Then we highlight the effect of S100A8/A9 heterodimer in the early inflammatory period and the late reparative period of MI as well as myocardial ischemia/reperfusion (I/R) injury. Moreover, the predictive value of S100A8/A9 for the risk of recurrence of cardiovascular events is elucidated. Therefore, this review focuses on the molecular mechanisms of S100A8/A9 in MI pathogenesis to provide a promising biomarker and therapeutic target for MI.

2 March 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
QWQing-Qing Wu
Qing-Qing Wu
CLChen Liu
Chen Liu
ZCZhulan Cai
Zhulan Cai
QXQingwen Xie
Qingwen Xie
THTongtong Hu
Tongtong Hu
QTQi-Zhu Tang
Qi-Zhu Tang
High-mobility group AT-hook1 (HMGA1, formerly HMG-I/Y), an architectural transcription factor, participates in a number of biological processes. However, its effect on cardiac remodeling (refer to cardiac inflammation, apoptosis and dysfunction) in diabetic cardiomyopathy remains largely indistinct. In this study, we found that HMGA1 was upregulated in diabetic mouse hearts and high-glucose-stimulated cardiomyocytes. Overexpression of HMGA1 accelerated high-glucose-induced cardiomyocyte inflammation and apoptosis, while HMGA1 knockdown relieved inflammation and apoptosis in cardiomyocytes in response to high glucose. Overexpression of HMGA1 in mice heart by adeno-associated virus 9 (AAV9) delivery system deteriorated the inflammatory response, increased apoptosis and accelerated cardiac dysfunction in streptozotocin-induced diabetic mouse model. Knockdown of HMGA1 by AAV9-shHMGA1 in vivo ameliorated cardiac remodeling in diabetic mice. Mechanistically, we found that HMGA1 inhibited the formation rather than the degradation of autophagy by regulating P27/CDK2/mTOR signaling. CDK2 knockdown or P27 overexpression blurred HMGA1 overexpression-induced deteriorating effects in vitro. P27 overexpression in mice heart counteracted HMGA1 overexpression-induced increased cardiac remodeling in diabetic mice. The luciferase reporter experiment confirmed that the regulatory effect of HMGA1 on P27 was mediated by miR-222. In addition, a miR-222 antagomir counteracted HMGA1 overexpression-induced deteriorating effects in vitro. Taken together, our data indicate that HMGA1 aggravates diabetic cardiomyopathy by directly regulating miR-222 promoter activity, which inhibits P27/mTOR-induced autophagy.

3 November 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
QWQing-Qing Wu
Qing-Qing Wu
WDWei Deng
Wei Deng
YXYang Xiao
Yang Xiao
JCJiao-Jiao Chen
Jiao-Jiao Chen
CLChen Liu
Chen Liu
QTQi-Zhu Tang
Qi-Zhu Tang
Zileuton has been demonstrated to be an anti-inflammatory agent due to its well-known ability to inhibit 5-lipoxygenase (5-LOX). However, the effects of zileuton on cardiac remodeling are unclear. In this study, the effects of zileuton on pressure overload-induced cardiac remodeling were investigated and the possible mechanisms were examined. Aortic banding was performed on mice to induce a cardiac remodeling model, and the mice were then treated with zileuton 1 week after surgery. We also stimulated neonatal rat cardiomyocytes with phenylephrine (PE) and then treated them with zileuton. Our data indicated that zileuton protected mice from pressure overload-induced cardiac hypertrophy, fibrosis, and oxidative stress. Zileuton also attenuated PE-induced cardiomyocyte hypertrophy in a time- and dose-dependent manner. Mechanistically, we found that zileuton activated PPARα, but not PPARγ or PPARθ, thus inducing Keap and NRF2 activation. This was confirmed with the PPARα inhibitor GW7647 and NRF2 siRNA, which abolished the protective effects of zileuton on cardiomyocytes. Moreover, PPARα knockdown abolished the anticardiac remodeling effects of zileuton in vivo. Taken together, our data indicate that zileuton protects against pressure overload-induced cardiac remodeling by activating PPARα/NRF2 signaling.

1 November 2019 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
MDMing Xia Duan
Ming Xia Duan
YYYuan Yuan
Yuan Yuan
CLChen Liu
Chen Liu
ZCZhulan Cai
Zhulan Cai
QXQingwen Xie
Qingwen Xie
QWQing Qing Wu
Qing Qing Wu
Inflammation, oxidative stress and apoptosis have been implicated in the pathogenesis of lipopolysaccharide (LPS)-induced cardiac dysfunction. Aucubin (AUB) has been found to possess anti-inflammatory and anti-apoptotic properties, but its effect on LPS-induced cardiac dysfunction is not clear. The present study investigated the effect of AUB on LPS-induced cardiac injury and the underlying molecular mechanism. Male C57BL/6 mice were received LPS injection (one 6 mg/kg injection of LPS) to induce cardiac dysfunction without or with AUB pretreatment (20 mg/kg or 80 mg/kg body weight per day) for 7 days. We found that AUB ameliorated cardiac dysfunction, inflammation, oxidative stress and apoptosis induced by LPS stimulation. AUB also decreased inflammatory cytokines expression, reduced oxidative stress and cell apoptosis induced by LPS stimulation in neonatal rat cardiomyocytes. Mechanically, we found that AUB inhibited thioredoxin interaction protein (TXNIP), NLRP3/ASC/caspase1 inflammasome formation in response to LPS stimulation in cardiomyocytes. Moreover, overexpression of NLRP3 in cardiomyocytes attenuated the protective effects of AUB. Interesting, NLRP3-deficiency exhibited ameliorated cardiac function and reduced inflammation response and oxidative stress after LPS insult in mice, while AUB could not further protect against LPS induced cardiac dysfunction in NLRP3-deficiency mice. In summary, AUB exerts a protective effect against LPS-induced cardiac dysfunction in an NLRP3 inflammasome-dependent manner. Hence, AUB might be a promising agent for the treatment of LPS-induced cardiac dysfunction. SIGNIFICANCE STATEMENT Aucubin exerts a protective effect against LPS-induced cardiac dysfunction by regulating NLRP3 inflammasome.

10 August 2022 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
PDF file
QWQing-Qing Wu
Qing-Qing Wu
QYQi Yao
Qi Yao
THTong-Tong Hu
Tong-Tong Hu
YWYing Wan
Ying Wan
QXQing-Wen Xie
Qing-Wen Xie
QTQi-Zhu Tang
Qi-Zhu Tang
Tax1 banding protein 1 (Tax1bp1) was originally identified as an NF-κB regulatory protein that participated in inflammatory, antiviral and innate immune processes. Tax1bp1 also functions as an autophagy receptor that plays a role in autophagy. Our previous study shows that Tax1bp1 protects against cardiomyopathy in STZ-induced diabetic mice. In this study we investigated the role of Tax1bp1 in heart failure. Pressure overload-induced heart failure model was established in mice by aortic banding (AB) surgery, and angiotensin II (Ang II)-induced heart failure model was established by infusion of Ang II through osmotic minipump for 4 weeks. We showed that the expression levels of Tax1bp1 in the heart were markedly increased 2 and 4 weeks after AB surgery. Knockdown of Tax1bp1 in mouse hearts significantly ameliorated both AB- and Ang II infusion-induced heart failure parameters. On the contrary, AB-induced heart failure was aggravated in cardiac-specific Tax1bp1 transgenic mice. Similar results were observed in neonatal rat cardiomyocytes (NRCMs) under Ang II insult. We demonstrated that the pro-heart failure effect of Tax1bp1 resulted from its interaction with the E3 ligase ITCH to promote the transcription factor P73 ubiquitination and degradation, causing enhanced BCL2 interacting protein 3 (BNIP3)-mediated cardiomyocyte apoptosis. Knockdown ITCH or BNIP3 in NRCMs significantly reduced Ang II-induced apoptosis in vitro. Similarly, BNIP3 knockdown attenuated heart failure in cardiac-specific Tax1bp1 transgenic mice. In the left ventricles of heart failure patients, Tax1bp1 expression level was significantly increased; Tax1bp1 gene expression was negatively correlated with left ventricular ejection fraction in heart failure patients. Collectively, the Tax1bp1 increase in heart failure enhances ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis and induced cardiac injury. Tax1bp1 may serve as a potent therapeutic target for the treatment of heart failure. • Cardiac Tax1bp1 transgene mice were more vulnerable to cardiac dysfunction under stress. • Cardiac Tax1bp1 transgene mice were more vulnerable to cardiac dysfunction under stress. • Knockout of Tax1bp1 in mouse hearts ameliorated heart failure induced by pressure overload. • Tax1bp1 interacts with the E3 ligase Itch to promote P73 ubiquitination and degradation, causing enhanced BNIP3-mediated apoptosis. • Tax1bp1 may become a target of new therapeutic methods for treating heart failure.